HSBC Holdings
FLNA

HSBC Holdings’s Filana Therapeutics FLNA Stock Holding History

HSBC Holdings’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$16.8K – 3167
2026
Q1 		$16.8K Hold
10,000
– – ﹤0.01% 2860
2025
Q4 		$19.7K Sell
10,000
-105
-1% -$336 ﹤0.01% 2899
2025
Q3 		$29.6K Hold
10,105
– – ﹤0.01% 2667
2025
Q2 		$18.6K Sell
10,105
-4,626
-31% -$8.23K ﹤0.01% 2981
2025
Q1 		$23K Sell
14,731
-31
-0.2% -$78 ﹤0.01% 2961
2024
Q4 		$33.9K Buy
+14,762
New +$259K ﹤0.01% 3029

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

HSBC Holdings's FLNA Position: Q2 2026 in Review

HSBC Holdings sold out of Filana Therapeutics (FLNA) in Q2 2026, closing a stake of 10,000 shares — an estimated $16.8K sold.

HSBC Holdings first reported a position in FLNA in Q4 2024 and held it in 6 quarters. The position peaked at $33.9K in Q4 2024. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • HSBC Holdings reported no remaining Filana Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HSBC Holdings sold 10,000 Filana Therapeutics shares in Q2 2026, an estimated $16.8K.
  • HSBC Holdings first reported a position in Filana Therapeutics in Q4 2024 and held it in 6 quarters.
  • HSBC Holdings's Filana Therapeutics position peaked at $33.9K in Q4 2024.
  • 85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.